Circulating Gastric Cancer Stem Cells as Blood Screening and Prognosis Factor in Gastric Cancer
Gastric cancer (GC) is the fourth leading cause of cancer-related death, associated with late diagnosis and treatment resistance. Currently, screening tests for GC are not cost-effective or have low accuracy. Previously, we described an extended phenotype of gastric cancer stem cells (GCSCs; CD24+CD...
Saved in:
| Main Authors: | Jared Becerril-Rico, Julian Grandvallet-Contreras, M. Patricia Ruíz-León, Sebastián Dorantes-Cano, Lizbeth Ramírez-Vidal, José M. Tinajero-Rodríguez, Elizabeth Ortiz-Sánchez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2024/9999155 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Association of HOTAIR with the Diagnosis and Prognosis of Gastric Cancer and Its Effect on the Proliferation of Gastric Cancer Cells
by: Zhiying Xu, et al.
Published: (2019-01-01) -
Extensive methylation analysis of circulating tumor DNA in plasma of patients with gastric cancer
by: Shinnosuke Nagano, et al.
Published: (2024-12-01) -
Surrounding Gastric Mucosa Findings Facilitate Diagnosis of Gastric Neoplasm as Gastric Adenoma or Early Gastric Cancer
by: Tadashi Miike, et al.
Published: (2016-01-01) -
Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on cholesterol metabolism in gastric cancer
by: Chengjun Zhu, et al.
Published: (2024-12-01) -
Diagnosis and prognosis prediction of gastric cancer by high-performance serum lipidome fingerprints
by: Ze-Rong Cai, et al.
Published: (2024-11-01)